At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 30 enrolled
Drug / intervention
tacrolimus ointmentdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit
In Brief
A Phase 4 clinical trial evaluating tacrolimus ointment for Atopic Dermatitis. Completed, enrolled 30 participants across 1 site.
Detailed Summary
The purpose of this research study is to better understand how the study drug works when people use it to treat atopic dermatitis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtopic Dermatitis
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2008
First PostedApr 2008
Primary CompletionSep 2009
TodayJul 2026
First PostedApr 8, 2008
Enrollment StartApr 1, 2008
Primary CompletionSep 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 18.2 years ago
Interventions
tacrolimus ointmentdrug
tacrolimus ointment to be applied twice daily to affected areas during duration of study